TRB Chemedica Competitors and Similar CompaniesClear all

Cosmo Pharmaceuticals's competitors and similar companies include Repligen, Swedish Orphan Biovitrum and Noven Pharmaceuticals.
Cosmo Pharmaceuticals
Cosmo Pharmaceuticals
Cosmo Pharmaceuticals is a company that focuses on solutions in the areas of astroenterology and endoscopy.
Repligen
Repligen
Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems.
Swedish Orphan Biovitrum
Swedish Orphan Biovitrum
Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care.
Noven Pharmaceuticals
Noven Pharmaceuticals
Noven Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing, and sale of prescription pharmaceutical products.
Founding Date
Founding Date
1997
Founding Date
1981
Founding Date
2010
Founding Date
1987
Type
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Dublin, IE HQ
Locations
Waltham, US HQ
Shanghai, CN
Jüri, EE
Castanet Tolosan, FR
Ravensburg, DE
Bengaluru, IN
Waterford, IE
see more
Locations
Solna, SE HQ
Sydney, AU
Wien, AT
Zaventem, BE
Sofia, BG
Oakville, CA
Beijng, CN
see more
Locations
Jersey City, US HQ
Miami, US
Employees
Employees
339
Employees
1,78312% decrease
Employees
1,8401% increase
Employees
9401% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
7.7 b
Valuation ($)
11.1 b
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
€266.8m (FY, 2024)
Revenue (est.)
$634.4m (FY, 2024)
Revenue (est.)
kr26b (FY, 2024)
Revenue (est.)
N/A
Cost of goods
Cost of goods
€41.4m (FY, 2024)
Cost of goods
$359.8m (FY, 2024)
Cost of goods
kr5.8b (FY, 2024)
Cost of goods
N/A
Gross profit
Gross profit
€229.1m (FY, 2024)
Gross profit
$274.6m (FY, 2024)
Gross profit
kr20.3b (FY, 2024)
Gross profit
N/A
Net income
Net income
€133.2m (FY, 2024)
Net income
($25.5m) (FY, 2024)
Net income
kr3.9b (FY, 2024)
Net income
N/A
For sources of this data, please see the company profile

View Company Profiles

Repligen
HQ
Waltham, US
Employees
1,783↓ 12% decrease

Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems.

View company
Swedish Orphan Biovitrum
HQ
Solna, SE
Employees
1,840↑ 1% increase

Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care.

View company
Noven Pharmaceuticals
HQ
Jersey City, US

Noven Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing, and sale of prescription pharmaceutical products.

View company